Cargando…

Rare ovarian tumours. Other treatments for ovarian cancer

AIM: The description of rare malignant ovarian tumours and the most suitable treatments. Alternative therapies different from intravenous chemotherapy are also explained. METHODS: Literature review and ongoing trial information have been used to elaborate this guide. RESULTS: Each ovarian cancer typ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gil-Martin, Marta, Pardo, Beatriz, Barretina-Ginesta, Maria-Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573466/ https://www.ncbi.nlm.nih.gov/pubmed/33240448 http://dx.doi.org/10.1016/j.ejcsup.2019.11.002

Ejemplares similares

DNA damaging agents in ovarian cancer
por: Barretina-Ginesta, Maria-Pilar
Publicado: (2020)

Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients
por: Halvorsen, Ann Rita, et al.
Publicado: (2017)

Esophageal Infiltration by High-Grade Serous Ovarian Carcinoma: A Very Rare Case Report
por: Carbó-Bagué, Anna, et al.
Publicado: (2023)

Management of advanced ovarian cancer in Spain: an expert Delphi consensus
por: Redondo, Andres, et al.
Publicado: (2021)

Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery
por: Plaja, Andrea, et al.
Publicado: (2023)

Update on new treatments for rare ovarian tumours
por: Quesada, Stanislas, et al.
Publicado: (2023)

SEOM clinical guideline in ovarian cancer (2020)
por: Redondo, A., et al.
Publicado: (2021)

Controversies in the treatment of advanced ovarian cancer in the PARP inhibitors era: a Delphi consensus
por: Redondo, Andrés, et al.
Publicado: (2023)

Primary ovarian leiomyoma: a rare ovarian tumour
por: Pervan, Mascha, et al.
Publicado: (2022)

Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey
por: Woopen, Hannah, et al.
Publicado: (2023)

Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial
por: Moreno, Victor, et al.
Publicado: (2021)

Ovarian tumours and other ovarian changes induced in mice by two 19-nor-contraceptives.
por: Lipschutz, A., et al.
Publicado: (1967)

Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor
por: Romeo, Margarita, et al.
Publicado: (2013)

Erratum to: Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor
por: Romeo, Margarita, et al.
Publicado: (2016)

Tumour antigenicity in ovarian cancer.
por: Levin, L., et al.
Publicado: (1975)

Advanced Ovarian Cancer during Pregnancy. Tumour Evolution Analysis and Treatment Approach
por: Bueno Moral, Ana Isabel, et al.
Publicado: (2021)

SEOM Clinical Guideline in ovarian cancer (2016)
por: Santaballa, A., et al.
Publicado: (2016)

The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study
por: Fernández-Serra, Antonio, et al.
Publicado: (2023)

Fertility sparing treatment in borderline ovarian tumours
por: Alvarez, Rosa Maria, et al.
Publicado: (2015)

Observations on Thirty Cases of Abdominal Section for Ovarian and Other Cystic Tumours
por: Cameron, H. C.
Publicado: (1887)

Two Cases of Strangulated Ovarian Tumour, with Symptoms Suggestive of Other Conditions
por: Weir, James
Publicado: (1907)

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.
por: Friedlander, M. L., et al.
Publicado: (1985)

TGFβ Controls Ovarian Cancer Cell Proliferation
por: Alsina-Sanchís, Elisenda, et al.
Publicado: (2017)

Ovarian Tumours and Ovariotomy
Publicado: (1873)

Size of Ovarian Tumours
por: Green, C. R. M.
Publicado: (1900)

Fertility preservation in ovarian tumours
por: Tomao, Federica, et al.
Publicado: (2018)

Ovulation and extra-ovarian origin of ovarian cancer
por: Yang-Hartwich, Yang, et al.
Publicado: (2014)

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Malignant ovarian mixed germ cell tumour: a rare combination
por: Koshy, M, et al.
Publicado: (2005)

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial
por: Barretina-Ginesta, Maria-Pilar, et al.
Publicado: (2022)

Ovarian Tumour with Masculinizing Syndrome
por: Cooray, G. H., et al.
Publicado: (1954)

Familial Ovarian Cancer Clusters with Other Cancers
por: Zheng, Guoqiao, et al.
Publicado: (2018)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
por: Garcia-Casado, Zaida, et al.
Publicado: (2022)

Pregnancy Complicated by Ovarian Tumours
Publicado: (1908)

A Case of Ovarian Tumour
por: Fink, G. H.
Publicado: (1891)

Ovarian Tumour: Operation—Death
por: White, H. P. Esmonde
Publicado: (1893)

Case of Ovarian Cystic Tumour
por: Millar, John
Publicado: (1868)

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
por: Jang, Ji Yon Agnes, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pgke04cnbsaiu28etp4np9bhtn